All Rankings

Recently Funded Biotech Companies 2026

Biotechnology and genomics companies whose latest recorded funding round was announced in the last 90 days.

Known total funding for 53 of 56 ranked companies: $8.1B.

Showing top 56 matching companies · Ranked by most recent funding

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&fundedAfter=2026-08-11&operatingStatus=active&sort=last_funding_date&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by most recent announced round. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

26
Aptadir Therapeutics

Aptadir Therapeutics develops RNA-based platforms that selectively inhibit DNMT1 globally or at s...

1–10Biotech, Healthcare
SeedTotal funding$45.0MSep 2026
27
Tinyhealth

Tiny Health provides at-home microbiome testing kits and gut-health guidance for infants, adults,...

Austin, United States11–50Healthcare, Biotech
Series BTotal funding$46.0MSep 2026
28
BigHat

BigHat Biosciences is a clinical-stage San Mateo biotech that designs antibody therapeutics by co...

San Mateo, United States51–200Artificial Intelligence, Biotech
Series CTotal funding$219.3MSep 2026
29
Basecamp Research

Builds evolutionary biological datasets and foundation AI models to design proteins and therapeut...

London, United Kingdom11–50Artificial Intelligence, Biotech
Series CTotal funding$220.0MSep 2026
30
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
31
Axo Longevity

Axo Longevity provides members with comprehensive biomarker testing, personalised health blueprin...

Menlo Park, United States11–50Biotech, Digital Health
SeedTotal funding$5.0MSep 2026
32
Circle Pharma

Operating discovery engine for cell-permeable macrocyclic peptide therapeutics

United States51–200Biotech, Healthcare
Series ETotal funding$227.5MSep 2026
33
Sling Therapeutics

Sling Therapeutics develops late-stage therapies for thyroid eye disease with experienced executi...

Ann Arbor, United States1–10Biotech, Healthcare
Series CTotal funding$158.0MSep 2026
34
Evvy

At-home vaginal microbiome testing and care platform offering metagenomic sequencing, clinician-r...

San Francisco, United States11–50Life Sciences, Biotech
Series BTotal funding$59.0MSep 2026
35
Artcline

ARTCLINE develops an extracorporeal immune-cell therapy that uses healthy donor cells to treat ba...

Rostock, Germany11–50Biotech, Diagnostics
Venture RoundSep 2026
36
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United States51–200Biotech, Therapeutics
Series FTotal funding$514.0MSep 2026
37
TwoStep Therapeutics

TwoStep Therapeutics is developing a pipeline built around a versatile peptide that selectively b...

San Carlos, United States1–10Biotech, Drug Discovery
Series ATotal funding$90.1MSep 2026
38
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Series BTotal funding$155.5MSep 2026
39
NovaGo Therapeutics

Swiss clinical-stage biotech company developing human antibody therapeutics that target nerve gro...

Schlieren, Switzerland1–10Biotech
Series BTotal funding$41.0MSep 2026
40
Biossil

AI-native biopharma drug discovery platform developing targeted therapies for biologically define...

Toronto, Canada1–10Artificial Intelligence, Biotech
Venture RoundTotal funding$153.0MSep 2026
41
RAMONA OPTICS INC

R&D company with 12 SBIR/STTR awards from Department of Health and Human Services, National Scien...

Durham, United States11–50Biotech, Healthcare
Series ATotal funding$32.7MSep 2026
42
EIT Pharma

EIT Pharma develops treatments for chronic hepatitis D and acute respiratory infection, with cand...

Kirkland, United States1–10Biotech, Healthcare
Series ATotal funding$35.0MAug 2026
43
AusperBio

AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV tr...

San Francisco, United StatesBiotech, Healthcare
Series CTotal funding$183.0MAug 2026
44
Airway Therapeutics

Airway Therapeutics develops zelpultide alfa, a recombinant protein for acute and chronic inflamm...

Marietta, United States1–10Biotech, Drug Discovery
Series ETotal funding$50.0MAug 2026
45
Pixelgen Technologies

Swedish biotech that uses DNA-based Proximity Network Assay technology to map cell-surface protei...

Stockholm, Sweden11–50Biotech, Manufacturing
Series BTotal funding$15.5MAug 2026
46
KaliVir Immunotherapeutics

KaliVir Immunotherapeutics develops next-generation oncolytic viral immunotherapy programs for ca...

Pittsburgh, United States11–50Biotech, Healthcare
Extension RoundTotal funding$14.0MAug 2026
47
Kynexis

Active investment

Naarden, Netherlands11–50Biotech, Healthcare
Extension RoundAug 2026
48
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series DTotal funding$473.3MAug 2026
49
Computomics

Computomics uses machine learning to analyse genomic data for agricultural, biotech, microbiome a...

Tubingen, GermanyAgtech, Artificial Intelligence
Series BTotal funding$7.3MAug 2026
50
Craif

Craif develops next-generation tests for early disease detection and personalized medicine, focus...

Nagoya, Japan11–50Artificial Intelligence, Biotech
Series DTotal funding$55.0MAug 2026